<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00588952</url>
  </required_header>
  <id_info>
    <org_study_id>0103012310</org_study_id>
    <secondary_id>VA Alcohol Research Center</secondary_id>
    <secondary_id>P50AA012870</secondary_id>
    <nct_id>NCT00588952</nct_id>
  </id_info>
  <brief_title>Ketamine/Placebo Family History Positive Study</brief_title>
  <official_title>NMDA Dysregulation in Individuals With a Family Vulnerability to Alcoholism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>VA Connecticut Healthcare System</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute on Alcohol Abuse and Alcoholism (NIAAA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed study is the first to explore the contribution of brain glutamate systems, a
      major target of ethanol in the brain, to the vulnerability to develop alcoholism. This study
      may lead to an enhanced understanding of the underlying neurobiological mechanism in
      high-risk individuals that may lead to the transition from moderate to excessive use of
      alcohol.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Males and females with a paternal family history of alcoholism have a high risk for
      developing alcoholism. These individuals have been shown to decrease dysphoric responses to
      alcohol self-administration that may promote the excessive use of alcohol. Ethanol has been
      shown to be an antagonist at the N-methyl-D-aspartate (NMDA) glutamate receptor. We have
      recently shown that sober alcoholics have decreased dysphoric response to the NMDA
      antagonist, ketamine. We propose to test the hypothesis that this characteristic exists as a
      vulnerability factor in those individuals susceptible to develop alcoholism. Specifically,
      the objective is to determine whether individuals with a family history positive (FHP) for
      alcoholism will experience less dysphoric, anxiogenic, and psychotogenic effects to ketamine
      infusion when compared to family history negative (FHN) control subjects.

      Male and female subjects, FHP (biological father and one other first degree relative) between
      the ages of 21-30, and matched controls (FHN) will complete 2 test days in a randomized
      balanced order under double-blind conditions. Test days will involve the 60-minute
      intravenous infusion of placebo and ketamine. Outcome measures include the Biphasic Alcohol
      Scale and visual analog scales for mood states. Secondary measures include visual analog
      scales for high, similarity to ethanol, the Sensation Scale (a validated measure of
      ethanol-like sensations) and aspects of craving for alcohol.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2001</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Biphasic Alcohol Effects Scale (BAES) - Subscale Sedation</measure>
    <time_frame>Baseline</time_frame>
    <description>Self-reporting rating scale to measure the sedative effects (0 not at all sedated - 70 extremely sedated) of alcohol</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Biphasic Alcohol Effects Scale (BAES) - Subscale Sedation</measure>
    <time_frame>15 minutes</time_frame>
    <description>Self-reporting rating scale to measure the sedative effects (0 not at all sedated - 70 extremely sedated) of alcohol</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Biphasic Alcohol Effects Scale (BAES) - Subscale Sedation</measure>
    <time_frame>45 minutes</time_frame>
    <description>Self-reporting rating scale to measure the sedative effects (0 not at all sedated - 70 extremely sedated) of alcohol</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Biphasic Alcohol Effects Scale (BAES) - Subscale Sedation</measure>
    <time_frame>80 minutes</time_frame>
    <description>Self-reporting rating scale to measure the sedative effects (0 not at all sedated - 70 extremely sedated) of alcohol</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Biphasic Alcohol Effects Scale (BAES) - Subscale Stimulation</measure>
    <time_frame>Baseline</time_frame>
    <description>Self-reporting rating scale to measure the stimulation effects (0 not at all stimulated - 70 extremely stimulated) of alcohol</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Biphasic Alcohol Effects Scale (BAES) - Subscale Stimulation</measure>
    <time_frame>15 minutes</time_frame>
    <description>Self-reporting rating scale to measure the stimulation effects (0 not at all stimulated - 70 extremely stimulated) of alcohol</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Biphasic Alcohol Effects Scale (BAES) - Subscale Stimulation</measure>
    <time_frame>45 minutes</time_frame>
    <description>Self-reporting rating scale to measure the stimulation effects (0 not at all stimulated - 70 extremely stimulated) of alcohol</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Biphasic Alcohol Effects Scale (BAES) - Subscale Stimulation</measure>
    <time_frame>80 minutes</time_frame>
    <description>Self-reporting rating scale to measure the stimulation effects (0 not at all stimulated - 70 extremely stimulated) of alcohol</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">99</enrollment>
  <condition>Alcoholism</condition>
  <arm_group>
    <arm_group_label>Family History Positive</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects with a positive family history of alcoholism</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Family History Negative</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects with a negative family history of alcoholism</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine and Placebo</intervention_name>
    <description>Two test days will involve administration of placebo and Ketamine (0.23 mg/kg, loading dose and infusion rate 0.58 mg/kg/minute) intravenously for 60 minutes</description>
    <arm_group_label>Family History Positive</arm_group_label>
    <arm_group_label>Family History Negative</arm_group_label>
    <other_name>intravenous</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male and female between the ages of 21 and 30 years

          2. Medically and neurologically healthy on the basis of history, physical examination,
             EKG, screening laboratories, absence of current and/or past substance abuse

        For Family History Positive (FHP) Subjects: Biological father and another first or
        second-degree biological relative with history of alcoholism

        Exclusion Criteria:

          1. Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV)
             psychiatric and substance abuse diagnosis by history on psychiatric evaluation that
             includes a structured diagnostic interview (The Semi-Structured Assessment for the
             Genetics of alcoholism: SSAGA) and the Wisconsin Scales of Psychosis Proneness

          2. History of counseling or psychotherapy; except family therapy centered around another
             family member

          3. Extended unwillingness to remain alcohol-free for three days prior to testing and for
             the duration of the testing period

          4. For women: positive pregnancy test at screening or intention to engage in unprotected
             sex during the study

          5. Alcohol na√Øve

          6. Previous bad experience with ketamine

          7. Adoptee and no contact with family members

        For Family History Negative (FHN) Subjects: NO family history of alcoholism in any first or
        second-degree relatives (subjects must reliably report on three first-degree relatives)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ismene L. Petrakis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Connecticut Healthcare System</name>
      <address>
        <city>West Haven</city>
        <state>Connecticut</state>
        <zip>06516</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Yoon G, Pittman B, Limoncelli D, Krystal JH, Petrakis IL. Familial Alcoholism Risk and the Ratio of Stimulant to Sedative Effects of Ketamine. Biol Psychiatry. 2016 May 1;79(9):e69-70. doi: 10.1016/j.biopsych.2015.09.006. Epub 2015 Sep 25.</citation>
    <PMID>26475672</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 27, 2007</study_first_submitted>
  <study_first_submitted_qc>January 8, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 9, 2008</study_first_posted>
  <results_first_submitted>January 10, 2017</results_first_submitted>
  <results_first_submitted_qc>January 10, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">March 3, 2017</results_first_posted>
  <last_update_submitted>January 10, 2017</last_update_submitted>
  <last_update_submitted_qc>January 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alcoholism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Family History Positive</title>
          <description>Subjects with a positive family history of alcoholism
Ketamine and Placebo: Two test days will involve administration of placebo and Ketamine (0.23 mg/kg, loading dose and infusion rate 0.58 mg/kg/minute) intravenously for 60 minutes</description>
        </group>
        <group group_id="P2">
          <title>Family History Negative</title>
          <description>Subjects with a negative family history of alcoholism
Ketamine and Placebo: Two test days will involve administration of placebo and Ketamine (0.23 mg/kg, loading dose and infusion rate 0.58 mg/kg/minute) intravenously for 60 minutes</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="29"/>
                <participants group_id="P2" count="70"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="63"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All available data was utilized in the analysis using mixed models</population>
      <group_list>
        <group group_id="B1">
          <title>Family History Positive</title>
          <description>Subjects with a positive family history of alcoholism
Ketamine and Placebo: Two test days will involve administration of placebo and Ketamine (0.23 mg/kg, loading dose and infusion rate 0.58 mg/kg/minute) intravenously for 60 minutes</description>
        </group>
        <group group_id="B2">
          <title>Family History Negative</title>
          <description>Subjects with a negative family history of alcoholism
Ketamine and Placebo: Two test days will involve administration of placebo and Ketamine (0.23 mg/kg, loading dose and infusion rate 0.58 mg/kg/minute) intravenously for 60 minutes</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="29"/>
            <count group_id="B2" value="70"/>
            <count group_id="B3" value="99"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="70"/>
                    <measurement group_id="B3" value="99"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24.97" spread="3.02"/>
                    <measurement group_id="B2" value="24.13" spread="2.34"/>
                    <measurement group_id="B3" value="24.37" spread="2.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="36"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="70"/>
                    <measurement group_id="B3" value="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Biphasic Alcohol Effects Scale (BAES) - Subscale Sedation</title>
        <description>Self-reporting rating scale to measure the sedative effects (0 not at all sedated - 70 extremely sedated) of alcohol</description>
        <time_frame>Baseline</time_frame>
        <population>All available data was utilized in the analysis using mixed models</population>
        <group_list>
          <group group_id="O1">
            <title>Family History Positive</title>
            <description>Subjects with a positive family history of alcoholism
Ketamine: Ketamine: 0.23 mg/kg, loading dose and infusion rate 0.58 mg/kg/minute for 60 minutes, IV
Placebo: Placebo: loading dose and an infusion for 60 minutes saline solution</description>
          </group>
          <group group_id="O2">
            <title>Family History Negative</title>
            <description>Subjects with a negative family history of alcoholism
Ketamine: Ketamine: 0.23 mg/kg, loading dose and infusion rate 0.58 mg/kg/minute for 60 minutes, IV
Placebo: Placebo: loading dose and an infusion for 60 minutes saline solution</description>
          </group>
        </group_list>
        <measure>
          <title>Biphasic Alcohol Effects Scale (BAES) - Subscale Sedation</title>
          <description>Self-reporting rating scale to measure the sedative effects (0 not at all sedated - 70 extremely sedated) of alcohol</description>
          <population>All available data was utilized in the analysis using mixed models</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Ketamine</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="27"/>
                    <count group_id="O2" value="68"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.63" spread="1.15"/>
                    <measurement group_id="O2" value="0.96" spread="2.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Placebo</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="28"/>
                    <count group_id="O2" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.71" spread="2.18"/>
                    <measurement group_id="O2" value="1.25" spread="2.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Biphasic Alcohol Effects Scale (BAES) - Subscale Sedation</title>
        <description>Self-reporting rating scale to measure the sedative effects (0 not at all sedated - 70 extremely sedated) of alcohol</description>
        <time_frame>15 minutes</time_frame>
        <population>All available data was utilized in the analysis using mixed models</population>
        <group_list>
          <group group_id="O1">
            <title>Family History Positive</title>
            <description>Subjects with a positive family history of alcoholism
Ketamine: Ketamine: 0.23 mg/kg, loading dose and infusion rate 0.58 mg/kg/minute for 60 minutes, IV
Placebo: Placebo: loading dose and an infusion for 60 minutes saline solution</description>
          </group>
          <group group_id="O2">
            <title>Family History Negative</title>
            <description>Subjects with a negative family history of alcoholism
Ketamine: Ketamine: 0.23 mg/kg, loading dose and infusion rate 0.58 mg/kg/minute for 60 minutes, IV
Placebo: Placebo: loading dose and an infusion for 60 minutes saline solution</description>
          </group>
        </group_list>
        <measure>
          <title>Biphasic Alcohol Effects Scale (BAES) - Subscale Sedation</title>
          <description>Self-reporting rating scale to measure the sedative effects (0 not at all sedated - 70 extremely sedated) of alcohol</description>
          <population>All available data was utilized in the analysis using mixed models</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Ketamine</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="26"/>
                    <count group_id="O2" value="66"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.96" spread="14.92"/>
                    <measurement group_id="O2" value="24.74" spread="17.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Placebo</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="28"/>
                    <count group_id="O2" value="66"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.46" spread="7.12"/>
                    <measurement group_id="O2" value="1.36" spread="2.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Biphasic Alcohol Effects Scale (BAES) - Subscale Sedation</title>
        <description>Self-reporting rating scale to measure the sedative effects (0 not at all sedated - 70 extremely sedated) of alcohol</description>
        <time_frame>45 minutes</time_frame>
        <population>All available data was utilized in the analysis using mixed models</population>
        <group_list>
          <group group_id="O1">
            <title>Family History Positive</title>
            <description>Subjects with a positive family history of alcoholism
Ketamine: Ketamine: 0.23 mg/kg, loading dose and infusion rate 0.58 mg/kg/minute for 60 minutes, IV
Placebo: Placebo: loading dose and an infusion for 60 minutes saline solution</description>
          </group>
          <group group_id="O2">
            <title>Family History Negative</title>
            <description>Subjects with a negative family history of alcoholism
Ketamine: Ketamine: 0.23 mg/kg, loading dose and infusion rate 0.58 mg/kg/minute for 60 minutes, IV
Placebo: Placebo: loading dose and an infusion for 60 minutes saline solution</description>
          </group>
        </group_list>
        <measure>
          <title>Biphasic Alcohol Effects Scale (BAES) - Subscale Sedation</title>
          <description>Self-reporting rating scale to measure the sedative effects (0 not at all sedated - 70 extremely sedated) of alcohol</description>
          <population>All available data was utilized in the analysis using mixed models</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Ketamine</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="25"/>
                    <count group_id="O2" value="66"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.36" spread="12.49"/>
                    <measurement group_id="O2" value="25.06" spread="18.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Placebo</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="28"/>
                    <count group_id="O2" value="66"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.46" spread="4.34"/>
                    <measurement group_id="O2" value="1.64" spread="4.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Biphasic Alcohol Effects Scale (BAES) - Subscale Sedation</title>
        <description>Self-reporting rating scale to measure the sedative effects (0 not at all sedated - 70 extremely sedated) of alcohol</description>
        <time_frame>80 minutes</time_frame>
        <population>All available data was utilized in the analysis using mixed models</population>
        <group_list>
          <group group_id="O1">
            <title>Family History Positive</title>
            <description>Subjects with a positive family history of alcoholism
Ketamine: Ketamine: 0.23 mg/kg, loading dose and infusion rate 0.58 mg/kg/minute for 60 minutes, IV
Placebo: Placebo: loading dose and an infusion for 60 minutes saline solution</description>
          </group>
          <group group_id="O2">
            <title>Family History Negative</title>
            <description>Subjects with a negative family history of alcoholism
Ketamine: Ketamine: 0.23 mg/kg, loading dose and infusion rate 0.58 mg/kg/minute for 60 minutes, IV
Placebo: Placebo: loading dose and an infusion for 60 minutes saline solution</description>
          </group>
        </group_list>
        <measure>
          <title>Biphasic Alcohol Effects Scale (BAES) - Subscale Sedation</title>
          <description>Self-reporting rating scale to measure the sedative effects (0 not at all sedated - 70 extremely sedated) of alcohol</description>
          <population>All available data was utilized in the analysis using mixed models</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Ketamine</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="26"/>
                    <count group_id="O2" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.46" spread="12.16"/>
                    <measurement group_id="O2" value="9.99" spread="13.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Placebo</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="28"/>
                    <count group_id="O2" value="66"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.07" spread="3.16"/>
                    <measurement group_id="O2" value="0.92" spread="2.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Biphasic Alcohol Effects Scale (BAES) - Subscale Stimulation</title>
        <description>Self-reporting rating scale to measure the stimulation effects (0 not at all stimulated - 70 extremely stimulated) of alcohol</description>
        <time_frame>Baseline</time_frame>
        <population>All available data was utilized in the analysis using mixed models</population>
        <group_list>
          <group group_id="O1">
            <title>Family History Positive</title>
            <description>Subjects with a positive family history of alcoholism
Ketamine: Ketamine: 0.23 mg/kg, loading dose and infusion rate 0.58 mg/kg/minute for 60 minutes, IV
Placebo: Placebo: loading dose and an infusion for 60 minutes saline solution</description>
          </group>
          <group group_id="O2">
            <title>Family History Negative</title>
            <description>Subjects with a negative family history of alcoholism
Ketamine: Ketamine: 0.23 mg/kg, loading dose and infusion rate 0.58 mg/kg/minute for 60 minutes, IV
Placebo: Placebo: loading dose and an infusion for 60 minutes saline solution</description>
          </group>
        </group_list>
        <measure>
          <title>Biphasic Alcohol Effects Scale (BAES) - Subscale Stimulation</title>
          <description>Self-reporting rating scale to measure the stimulation effects (0 not at all stimulated - 70 extremely stimulated) of alcohol</description>
          <population>All available data was utilized in the analysis using mixed models</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Ketamine</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="27"/>
                    <count group_id="O2" value="68"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.78" spread="8.66"/>
                    <measurement group_id="O2" value="2.43" spread="7.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Placebo</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="28"/>
                    <count group_id="O2" value="66"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.36" spread="6.14"/>
                    <measurement group_id="O2" value="2.88" spread="7.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Biphasic Alcohol Effects Scale (BAES) - Subscale Stimulation</title>
        <description>Self-reporting rating scale to measure the stimulation effects (0 not at all stimulated - 70 extremely stimulated) of alcohol</description>
        <time_frame>15 minutes</time_frame>
        <population>All available data was utilized in the analysis using mixed models</population>
        <group_list>
          <group group_id="O1">
            <title>Family History Positive</title>
            <description>Subjects with a positive family history of alcoholism
Ketamine: Ketamine: 0.23 mg/kg, loading dose and infusion rate 0.58 mg/kg/minute for 60 minutes, IV
Placebo: Placebo: loading dose and an infusion for 60 minutes saline solution</description>
          </group>
          <group group_id="O2">
            <title>Family History Negative</title>
            <description>Subjects with a negative family history of alcoholism
Ketamine: Ketamine: 0.23 mg/kg, loading dose and infusion rate 0.58 mg/kg/minute for 60 minutes, IV
Placebo: Placebo: loading dose and an infusion for 60 minutes saline solution</description>
          </group>
        </group_list>
        <measure>
          <title>Biphasic Alcohol Effects Scale (BAES) - Subscale Stimulation</title>
          <description>Self-reporting rating scale to measure the stimulation effects (0 not at all stimulated - 70 extremely stimulated) of alcohol</description>
          <population>All available data was utilized in the analysis using mixed models</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Ketamine</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="26"/>
                    <count group_id="O2" value="66"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.39" spread="22.53"/>
                    <measurement group_id="O2" value="14.58" spread="15.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Placebo</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="28"/>
                    <count group_id="O2" value="66"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.82" spread="4.10"/>
                    <measurement group_id="O2" value="1.82" spread="5.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Biphasic Alcohol Effects Scale (BAES) - Subscale Stimulation</title>
        <description>Self-reporting rating scale to measure the stimulation effects (0 not at all stimulated - 70 extremely stimulated) of alcohol</description>
        <time_frame>45 minutes</time_frame>
        <population>All available data was utilized in the analysis using mixed models</population>
        <group_list>
          <group group_id="O1">
            <title>Family History Positive</title>
            <description>Subjects with a positive family history of alcoholism
Ketamine: Ketamine: 0.23 mg/kg, loading dose and infusion rate 0.58 mg/kg/minute for 60 minutes, IV
Placebo: Placebo: loading dose and an infusion for 60 minutes saline solution</description>
          </group>
          <group group_id="O2">
            <title>Family History Negative</title>
            <description>Subjects with a negative family history of alcoholism
Ketamine: Ketamine: 0.23 mg/kg, loading dose and infusion rate 0.58 mg/kg/minute for 60 minutes, IV
Placebo: Placebo: loading dose and an infusion for 60 minutes saline solution</description>
          </group>
        </group_list>
        <measure>
          <title>Biphasic Alcohol Effects Scale (BAES) - Subscale Stimulation</title>
          <description>Self-reporting rating scale to measure the stimulation effects (0 not at all stimulated - 70 extremely stimulated) of alcohol</description>
          <population>All available data was utilized in the analysis using mixed models</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Ketamine</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="25"/>
                    <count group_id="O2" value="66"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.4" spread="19.09"/>
                    <measurement group_id="O2" value="9.06" spread="12.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Placebo</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="28"/>
                    <count group_id="O2" value="66"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.54" spread="3.50"/>
                    <measurement group_id="O2" value="1.64" spread="5.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Biphasic Alcohol Effects Scale (BAES) - Subscale Stimulation</title>
        <description>Self-reporting rating scale to measure the stimulation effects (0 not at all stimulated - 70 extremely stimulated) of alcohol</description>
        <time_frame>80 minutes</time_frame>
        <population>All available data was utilized in the analysis using mixed models</population>
        <group_list>
          <group group_id="O1">
            <title>Family History Positive</title>
            <description>Subjects with a positive family history of alcoholism
Ketamine: Ketamine: 0.23 mg/kg, loading dose and infusion rate 0.58 mg/kg/minute for 60 minutes, IV
Placebo: Placebo: loading dose and an infusion for 60 minutes saline solution</description>
          </group>
          <group group_id="O2">
            <title>Family History Negative</title>
            <description>Subjects with a negative family history of alcoholism
Ketamine: Ketamine: 0.23 mg/kg, loading dose and infusion rate 0.58 mg/kg/minute for 60 minutes, IV
Placebo: Placebo: loading dose and an infusion for 60 minutes saline solution</description>
          </group>
        </group_list>
        <measure>
          <title>Biphasic Alcohol Effects Scale (BAES) - Subscale Stimulation</title>
          <description>Self-reporting rating scale to measure the stimulation effects (0 not at all stimulated - 70 extremely stimulated) of alcohol</description>
          <population>All available data was utilized in the analysis using mixed models</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Ketamine</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="26"/>
                    <count group_id="O2" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.81" spread="8.45"/>
                    <measurement group_id="O2" value="3.02" spread="8.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Placebo</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="28"/>
                    <count group_id="O2" value="66"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.61" spread="3.66"/>
                    <measurement group_id="O2" value="2.12" spread="6.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Family History Positive</title>
          <description>Subjects with a positive family history of alcoholism
Ketamine: Ketamine: 0.23 mg/kg, loading dose and infusion rate 0.58 mg/kg/minute for 60 minutes, IV
Placebo: Placebo: loading dose and an infusion for 60 minutes saline solution</description>
        </group>
        <group group_id="E2">
          <title>Family History Negative</title>
          <description>Subjects with a negative family history of alcoholism
Ketamine: Ketamine: 0.23 mg/kg, loading dose and infusion rate 0.58 mg/kg/minute for 60 minutes, IV
Placebo: Placebo: loading dose and an infusion for 60 minutes saline solution</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="70"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="70"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Vomiting</sub_title>
                <description>Subject vomited during infusion so infusion was stopped.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="70"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Anxiety</sub_title>
                <description>Subjects stopped infusion felt very anxious</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="70"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Ismene Petrakis</name_or_title>
      <organization>Yale University</organization>
      <phone>203-932-5711 ext 2244</phone>
      <email>Ismene.petrakis@yale.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

